To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
Ubiquitin pS65 Phosphospecific Antibody (WB/ICC/ELISA)
Antibody
Rabbit monoclonal phosphospecific antibody directed against Serine65 of ubiquitin. Suitable for immunoblot, immunocytochemistry, and ELISA applications.
Ubiquitinated-K266 VDAC1 Antibody
Antibody
Monoclonal antibody directed against ubiquitinated-K266 VDAC1. Please note: The antibody will not be made available as QC/QA of the antibody showed a lack of adequate sensitivity. Email tools@michaeljfox.org with questions or for more information.
VPS13C Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse VPS13C for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
VPS13C Knockout HeLa Cell Line
Immortalized Cell
HeLa cell with homozygous knockout of VPS13C.
Estimated Availability: Early 2025
VPS35 D620N Mouse
Mouse Model
Mice expressing the D620N mutant form of VPS35. RRID:IMSR_JAX:023409
VPS35 Plasmids
DNA Plasmids
DNA Plasmids encoding various VPS35 cDNA inserts
Wild Type Human Alpha-Synuclein Mouse
Mouse Model
Mice express a wild-type human alpha-synuclein gene directed by its endogenous promoter/enhancer regions on the BAC transgene. RRID:IMSR_JAX:018442
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic